Results 111 to 120 of about 2,325 (152)

Programmable DNAzyme nanocatalysts orchestrate redox-immune coupling for time-gated cancer immunomodulation. [PDF]

J Nanobiotechnology
Wang L, Luo R, Zou L, Liu X, Tang Z, Dong F, Wang Z, Lyu J, Zhang Y.   +8 more
europepmc   +1 more source

Nucleolin perturbation alters membrane lipid homeostasis.

Mol Omics
Zahavi EE, Rishal I, Oses-Prieto JA, Brandis A, Malitsky S, Itkin M, Pokorná Š, Cabrera-Cabrera F, Seeba NN, Risti R, Lõokene A, Futerman AH, Burlingame AL, Fainzilber M, Koppel I.   +14 more
europepmc   +1 more source

Dual-Mode Aptamer AP1-F Achieves Molecular-Morphological Precision in Cancer Diagnostics via Membrane NCL Targeting. [PDF]

Curr Issues Mol Biol
Yang Z, Wang L, Xiao C, Shen X.
europepmc   +1 more source

The emerging role of aptamers in targeted cancer immunotherapy. [PDF]

Mol Ther Oncol
Zhu S, Xu R, Xu H, Wang Y, Wang L, He N, Wang HH, Ren X.   +7 more
europepmc   +1 more source

Aptamer-Nanoconjugates as Potential Theranostics in Major Neuro-Oncological and Neurodegenerative Disorders. [PDF]

Pharmaceutics
Tauser RG, Lupascu FG, Profire BS, Iacob AT, Vasincu IM, Apotrosoaei M, Chirliu OM, Lupascu D, Profire L.   +8 more
europepmc   +1 more source

Innovative Applications of Nucleic Acid Aptamers in Colorectal Cancer Diagnosis and Therapy: From Selection Optimization to Clinical Translation. [PDF]

Int J Nanomedicine
Lu JF, Zhang XR, Liu Y, Zhang CL, Wang L, Liu ZQ, Cai J, Yi HW.   +7 more
europepmc   +1 more source

Aptamer-Based Delivery of Genes and Drugs Across the Blood-Brain Barrier. [PDF]

Pharmaceuticals (Basel)
Yang L, Yin Y, Liu X, Guo B.
europepmc   +1 more source

[Ultrasound-synergized targeted nanoparticles suppress proliferation, migration and invasion of hypoxic lung cancer cells <i>in vitro</i>]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Dong J, Guo J, Li D, DU Y.
europepmc   +1 more source

Aptamer-based applications in delivering cancer gene therapies and beyond: state of the art and the missing links to clinical translation. [PDF]

Adv Drug Deliv Rev
Coppola G, Cennamo F, Ciccone G, Ibba ML, Ruscio AD, Vito AD, Esposito CL, Catuogno S.   +7 more
europepmc   +1 more source